Company: SMNR
Filing Date: 2025-07-23
Form Type: S-4/A
Source: 0001193125-25-163401
Chunk: 336

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: S-4/A
Chunk 336
---
408 |
| Dr. Reddy’s Laboratories Limited (BSE:500124)      |     |               |  81.03 |     |             |   167 |     |           | — |     |              |  13,498 |
| Collegium Pharmaceutical, Inc. (NasdaqGS:COLL)     |     |               |  36.71 |     |             |    32 |     |           | — |     |              |   1,183 |
| AbbVie Inc. (NYSE:ABBV)                            |     |               | 191.23 |     |             | 1,766 |     |           | — |     |              | 337,778 |
| Axsome Therapeutics, Inc. (NasdaqGM:AXSM)          |     |               |  84.85 |     |             |    48 |     |           | — |     |              |   4,073 |

Notes:

| (1) | Values in thousands of US dollars, except stock price per share and shares outstanding. |

| (2) | Corresponding values continued in table below. |

| (3) | Source: S&P Capital IQ. |

Comparable Company Information (Continued)

| Comparable Company Names                           |     | Total    
 Interest 
 Bearing  
 Debt($)  |        |     | Total      
 Invested   
 Capital($) |         |     | Less: Cash($) |        |     | Total    
 Minority 
 Interest |   |     | Enterprise 
 Value($)   |         |
| Amgen Inc. (NasdaqGS:AMGN)                         |     |          | 65,423 |     |            | 239,222 |     |               | 10,944 |     |          | — |     |            | 228,278 |
| Pacira BioSciences, Inc. (NasdaqGS:PCRX)           |     |          |    586 |     |            |   1,158 |     |               |    153 |     |          | — |     |            |   1,005 |
| CVS Health Corporation (NYSE:CVS)                  |     |          | 79,385 |     |            | 149,605 |     |               |  8,196 |     |          | — |     |            | 141,409 |
| Pfizer Inc. (NYSE:PFE)                             |     |